Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Health Canada has authorized three influenza vaccines that could be used if bird flu became a pandemic, the agency says.

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

2:12 H5N1 avian influenza: B.C. reports 1st suspected human case of bird flu Health Canada has authorized three influenza vaccines that could be used if bird flu became a pandemic, the agency says.

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

The Kateri Memorial Hospital Centre will hold a walk-in vaccination clinic today in an effort to ensure that every local who wants a shot can get one.

Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.

TORONTO - Health Canada has approved Moderna’s mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won’t be available until next year, the company ...

Human-to-human transmission is very rare, but as cases among animals rise, many experts are worried the virus could develop ...

Moderna (MRNA) announced Health Canada has approved mRESVIA for active ... adults 60 years of age and older mRESVIA is the only RSV vaccine available in a pre-filled syringe.